Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hoiby, N' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 113 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Wu, H; Song, ZJ; Givskov, M; Doring, G; Worlitzsch, D; Mathee, K; Rygaard, J; Hoiby, N
      Pseudomonas aeruginosa mutations in lasl and rhll quorum sensing systems result in milder chronic lung infection

      MICROBIOLOGY-SGM
    2. Hoiby, N; Johansen, HK; Moser, C; Song, ZJ; Ciofu, O; Kharazmi, A
      Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth

      MICROBES AND INFECTION
    3. Fluge, G; Ojeniyi, B; Hoiby, N; Digranes, A; Ciofu, O; Hunstad, E; Haanaes, OC; Storrosten, OT
      Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients

      CLINICAL MICROBIOLOGY AND INFECTION
    4. Williams, JD; Naber, KG; Bryskier, A; Hoiby, N; Gould, IM; Periti, P; Giamarellou, H; Rouveix, B
      Classification of oral cephalosporins. A matter for debate

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    5. Hoiby, N
      Inflammation and infection in cystic fibrosis - hen or egg?

      EUROPEAN RESPIRATORY JOURNAL
    6. Jensen, P; Johansen, HK; Carmi, P; Hoiby, N; Cohen, IR
      Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis

      JOURNAL OF AUTOIMMUNITY
    7. Ciofu, O; Fussing, V; Bagge, N; Koch, C; Hoiby, N
      Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting

      Journal of antimicrobial chemotherapy
    8. Hoiby, N
      Antibodies against Pseudomonas aeruginosa in patients with bronchiectasis:helpful or harmful?

      THORAX
    9. Jensen, P; Johansen, HK; Lanng, S; Hoiby, N
      Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroELin prediabetic patients with cystic fibrosis

      PEDIATRIC RESEARCH
    10. Biering-Sorensen, F; Bagi, P; Hoiby, N
      Urinary tract infections in patients with spinal cord lesions - Treatment and prevention

      DRUGS
    11. Ojeniyi, B; Frederiksen, B; Hoiby, N
      Pseudomonas aeruginosa cross-infection among patients with cystic fibrosisduring a winter camp

      PEDIATRIC PULMONOLOGY
    12. Walther-Rasmussen, J; Hoiby, N
      Hydrophobic character of surface regions and total hydrophobicity of four variants of chromosomal class C beta-lactamase from Pseudomonas aeruginosa are identical. Chromatographic comparison of the hydrophobic character of the variants and the effect of focusing buffer composition on the separationof the variants by chromatofocusing with internal and external pH gradients

      JOURNAL OF CHROMATOGRAPHY B
    13. Biering-Sorensen, F; Schroder, AK; Wilhelmsen, M; Lomberg, B; Nielsen, H; Hoiby, N
      Bacterial contamination of bath-water from spinal cord lesioned patients with pressure ulcers exercising in the water

      SPINAL CORD
    14. Wu, H; Song, ZJ; Hentzer, M; Andersen, JB; Heydorn, A; Mathee, K; Moser, C; Eberl, L; Molin, S; Hoiby, N; Givskov, M
      Detection of N-acylhomoserine lactones in lung tissues of mice infected with Pseudomonas aeruginosa

      MICROBIOLOGY-UK
    15. Littlewood, JM; Koch, C; Lambert, PA; Hoiby, N; Elborn, JS; Conway, SP; Dinwiddie, R; Duncan-Skingle, F
      A ten year review of Colomycin

      RESPIRATORY MEDICINE
    16. Bagge, N; Ciofu, O; Skovgaard, LT; Hoiby, N
      Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal beta-lactamase

      APMIS
    17. Moser, C; Kjaergaard, S; Pressler, T; Kharazmi, A; Koch, C; Hoiby, N
      The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type

      APMIS
    18. Doring, G; Conway, SP; Heijerman, HGM; Hodson, ME; Hoiby, N; Smyth, A; Touw, DJ
      Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus

      EUROPEAN RESPIRATORY JOURNAL
    19. Nielsen, K; Bangsborg, JM; Hoiby, N
      Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    20. Geisenberger, O; Givskov, M; Riedel, K; Hoiby, N; Tummler, B; Eberl, L
      Production of N-acyl-L-homoserine lactones by P-aeruginosa isolates from chronic lung infections associated with cystic fibrosis

      FEMS MICROBIOLOGY LETTERS
    21. Hoiby, N
      Ecological antibiotic policy

      Journal of antimicrobial chemotherapy
    22. Wise, R; Jarlier, V; Naber, KG; Graninger, W; Nicolle, LE; Hooton, T; Cars, O; Hoiby, N; Bint, AJ; Mandell, L; Khalmeter; Brown, EM
      Progress in the management of urinary tract infections: discussion

      Journal of antimicrobial chemotherapy
    23. Ciofu, O; Beveridge, TJ; Kadurugamuwa, J; Walther-Rasmussen, J; Hoiby, N
      Chromosomal beta-lactamase is packaged into membrane vesicles and secretedfrom Pseudomonas aeruginosa

      Journal of antimicrobial chemotherapy
    24. Saiman, L; MacDonald, N; Burns, JL; Hoiby, N; Speert, DP; Weber, D
      Infection control in cystic fibrosis: Practical recommendations for the hospital, clinic, and social settings

      AMERICAN JOURNAL OF INFECTION CONTROL
    25. Collins, MT; Lisby, G; Moser, C; Chicks, D; Christensen, S; Reichelderfer, M; Hoiby, N; Harms, BA; Thomsen, OO; Skibsted, U; Binder, V
      Results of multiple diagnostic tests for Mycobacterium avium subsp paratuberculosis in patients with inflammatory bowel disease and in controls

      JOURNAL OF CLINICAL MICROBIOLOGY
    26. Jalal, S; Ciofu, O; Hoiby, N; Gotoh, N; Wretlind, B
      Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients (vol 44, pg 710, 2000)

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    27. Jalal, S; Ciofu, O; Hoiby, N; Gotoh, N; Wretlind, B
      Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    28. Nielsen, K; Hindersson, P; Hoiby, N; Bangsborg, JM
      Sequencing of the rpoB gene in Legionella pneumophila and characterizationof mutations associated with Rifampin resistance in the Legionellaceae

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    29. Hoiby, N; Pers, C; Johansen, HK; Hansen, H
      Excretion of beta-lactam antibiotics in sweat - a neglected mechanism for development of antibiotic resistance?

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    30. Hoiby, N; Koch, C
      Maintenance treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis

      THORAX
    31. Frederiksen, B; Koch, C; Hoiby, N
      Changing epidemiology of Pseudomonas aeruginosa infection in Danish cysticfibrosis patients (1974-1995)

      PEDIATRIC PULMONOLOGY
    32. Mathee, K; Ciofu, O; Sternberg, C; Lindum, PW; Campbell, JIA; Jensen, P; Johnsen, AH; Givskov, M; Ohman, DE; Molin, S; Hoiby, N; Kharazmi, A
      Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung

      MICROBIOLOGY-UK
    33. Moser, C; Hougen, HP; Song, ZJ; Rygaard, J; Kharazmi, A; Hoiby, N
      Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response

      APMIS
    34. Johansen, HK; Borch, K; Espersen, F; Koch, C; Hoiby, N
      Randomised trial of pivampicillin plus pivmecillinam vs. pivampicillin in children and young adults with chronic obstructive pulmonary disease and infection with Haemophilus influenzae

      CURRENT MEDICAL RESEARCH AND OPINION
    35. Kharazmi, A; Giwercman, B; Hoiby, N
      Robbins device in biofilm research

      BIOFILMS
    36. Ciofu, O; Petersen, TD; Jensen, P; Hoiby, N
      Avidity of anti-P aeruginosa antibodies during chronic infection in patients with cystic fibrosis

      THORAX
    37. Skov, M; Pressler, T; Jensen, HE; Hoiby, N; Koch, C
      Specific IgG subclass antibody pattern to Aspergillus fumigatus in patients with cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA)

      THORAX
    38. Kerr, JR; Taylor, GW; Rutman, A; Hoiby, N; Cole, PJ; Wilson, R
      Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth

      JOURNAL OF CLINICAL PATHOLOGY
    39. Garred, P; Pressler, T; Madsen, HO; Frederiksen, B; Svejgaard, A; Hoiby, N; Schwartz, M; Koch, C
      Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis

      JOURNAL OF CLINICAL INVESTIGATION
    40. Walther-Rasmussen, J; Johnsen, AH; Hoiby, N
      Terminal truncations in Amp C beta-lactamase from a clinical isolate of Pseudomonas aeruginosa

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    41. JOHANSEN HK; KOVESI TA; KOCH C; COREY M; HOIBY N; LEVISON H
      PSEUDOMONAS-AERUGINOSA AND BURKHOLDERIA-CEPACIA INFECTION IN CYSTIC-FIBROSIS PATIENTS TREATED IN TORONTO AND COPENHAGEN

      Pediatric pulmonology
    42. HAECKEL R; BOHM M; CAPEL PJA; HOIBY N; JANSEN RTP; KALLNER A; KELLY A; KRUSEJARRES JD; KUFFER H; LIBEER JC
      CONCEPTS FOR A MODEL OF GOOD MEDICAL LABORATORY SERVICES

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    43. MOSER C; KRIEGBAUM NJ; LARSEN SO; HOIBY N; BIERINGSORENSEN F
      ANTIBODIES TO URINARY-TRACT PATHOGENS IN PATIENTS WITH SPINAL-CORD LESIONS

      Spinal cord
    44. SONG ZJ; KHARAZMI A; WU H; FABER V; MOSER C; JOHANSEN HK; RYGAARD J; HOIBY N
      EFFECTS OF GINSENG TREATMENT ON NEUTROPHIL CHEMILUMINESCENCE AND IMMUNOGLOBULIN-G SUBCLASSES IN A RAT MODEL OF CHRONIC PSEUDOMONAS-AERUGINOSA PNEUMONIA

      Clinical and diagnostic laboratory immunology (Print)
    45. DANIELSEN L; BALSLEV E; DORING G; HOIBY N; MADSEN SM; AGREN M; THOMSEN HK; FOS HHS; WESTH H
      ULCER BED INFECTION - REPORT OF A CASE OF ENLARGING VENOUS LEG ULCER COLONIZED BY PSEUDOMONAS-AERUGINOSA

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    46. JARLOV JO; HOIBY N
      COAGULASE-NEGATIVE STAPHYLOCOCCI IN A MAJOR DANISH UNIVERSITY HOSPITAL - DIVERSITY IN ANTIBIOTIC SUSCEPTIBILITY BETWEEN WARDS

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    47. KJERULF A; ESPERSEN F; GUTSCHIK E; MAJCHERCZYK PA; HOUGEN HP; RYGAARD J; HOIBY N
      SEROLOGICAL DIAGNOSIS OF EXPERIMENTAL ENTEROCOCCUS-FAECALIS ENDOCARDITIS

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    48. LIVESLEY MA; BAXTER IA; LAMBERT PA; GOVAN JRW; WELLER PH; LACEY DE; ALLISON DG; GIWERCMAN B; HOIBY N
      SUBSPECIFIC DIFFERENTIATION OF BURKHOLDERIA-CEPACIA ISOLATES IN CYSTIC-FIBROSIS

      Journal of Medical Microbiology
    49. KJERULF A; TVEDE M; ALDERSHVILE J; HOIBY N
      BACTERIAL-ENDOCARDITIS AT A TERTIARY HOSPITAL - HOW DO WE IMPROVE DIAGNOSIS AND DELAY OF TREATMENT - A RETROSPECTIVE STUDY OF 140 PATIENTS

      Cardiology
    50. FREDERIKSEN B; KOCH C; HOIBY N
      ANTIBIOTIC-TREATMENT OF INITIAL COLONIZATION WITH PSEUDOMONAS-AERUGINOSA POSTPONES CHRONIC INFECTION AND PREVENTS DETERIORATION OF PULMONARY-FUNCTION IN CYSTIC-FIBROSIS

      Pediatric pulmonology
    51. BISGAARD H; PEDERSEN SS; NIELSEN KG; SKOV M; LAURSEN EM; KRONBORG G; REIMERT CM; HOIBY N; KOCH C
      CONTROLLED TRIAL OF INHALED BUDESONIDE IN PATIENTS WITH CYSTIC-FIBROSIS AND CHRONIC BRONCHOPULMONARY PSEUDOMONAS-AERUGINOSA INFECTION

      American journal of respiratory and critical care medicine
    52. SONG ZJ; JOHANSEN HK; FABER V; HOIBY N
      GINSENG TREATMENT ENHANCES BACTERIAL CLEARANCE AND DECREASES LUNG PATHOLOGY IN ATHYMIC RATS WITH CHRONIC PSEUDOMONAS-AERUGINOSA PNEUMONIA

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    53. ULANOVA M; PETERSEN TD; CIOFU O; JENSEN P; HAHNZORIC M; HANSON LA; HOIBY N
      THE CLONAL ANTIBODY-RESPONSE TO PSEUDOMONAS-AERUGINOSA HEAT-SHOCK-PROTEIN IS HIGHLY DIVERSE IN CYSTIC-FIBROSIS PATIENTS

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    54. MOSER C; JOHANSEN HK; SONG ZJ; HOUGEN HP; RYGAARD J; HOIBY N
      CHRONIC PSEUDOMONAS-AERUGINOSA LUNG INFECTION IS MORE SEVERE IN TH-2 RESPONDING BALB C MICE COMPARED TO TH-1 RESPONDING C3H/HEN MICE/

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    55. JENSEN ET; GIWERCMAN B; OJENIYI B; BANGSBORG JM; HANSEN A; KOCH C; FIEHN NE; HOIBY N
      EPIDEMIOLOGY OF PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS AND THE POSSIBLE ROLE OF CONTAMINATION BY DENTAL EQUIPMENT

      The Journal of hospital infection
    56. CAMPBELL JIA; CIOFU O; HOIBY N
      PSEUDOMONAS-AERUGINOSA ISOLATES FROM PATIENTS WITH CYSTIC-FIBROSIS HAVE DIFFERENT BETA-LACTAMASE EXPRESSION PHENOTYPES BUT ARE HOMOGENEOUS IN THE AMPC-AMPR GENETIC REGION

      Antimicrobial agents and chemotherapy
    57. SONG ZJ; JOHANSEN HK; FABER V; MOSER C; KHARAZMI A; RYGAARD J; HOIBY N
      GINSENG TREATMENT REDUCES BACTERIAL LOAD AND LUNG PATHOLOGY IN CHRONIC PSEUDOMONAS-AERUGINOSA PNEUMONIA IN RATS

      Antimicrobial agents and chemotherapy
    58. HJORTRUP A; RASMUSSEN A; HANSEN BA; HOIBY N; HESLET L; MOESGAARD F; KIRKEGAARD P
      EARLY BACTERIAL AND FUNGAL-INFECTIONS IN LIVER-TRANSPLANTATION AFTER ORAL SELECTIVE BOWEL DECONTAMINATION

      Transplantation proceedings
    59. GRAFF LB; ANDERSEN LP; BREMMELGAARD A; BONNEVIE O; BONDESEN S; GERNOW A; HOIBY N; DANNESKIOLDSAMSOE B
      ONE-YEAR FOLLOW-UP-STUDY ON PATIENTS WITH RHEUMATOID-ARTHRITIS (RA) AFTER ERADICATION OF HELICOBACTER-PYLORI

      Gut
    60. CIOFU O; PRESSLER T; PANDEY JP; HOIBY N
      THE INFLUENCE OF ALLOTYPES ON THE IGG SUBCLASS RESPONSE TO CHROMOSOMAL BETA-LACTAMASE OF PSEUDOMONAS-AERUGINOSA IN CYSTIC-FIBROSIS PATIENTS

      Clinical and experimental immunology
    61. FREDERIKSEN B; LANNG S; KOCH C; HOIBY N
      IMPROVED SURVIVAL IN THE DANISH CENTER-TREATED CYSTIC-FIBROSIS PATIENTS - RESULTS OF AGGRESSIVE TREATMENT

      Pediatric pulmonology
    62. RYLEY HC; OJENIYI B; HOIBY N; WEEKS J
      LACK OF EVIDENCE OF NOSOCOMIAL CROSS-INFECTION BY BURKHOLDERIA-CEPACIA AMONG DANISH CYSTIC-FIBROSIS PATIENTS

      European journal of clinical microbiology & infectious diseases
    63. SONG ZJ; JOHANSEN HK; MOSER C; HOIBY N
      EFFECTS OF CHINESE MEDICINAL HERBS ON A RAT MODEL OF CHRONIC PSEUDOMONAS-AERUGINOSA LUNG INFECTION

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    64. HOIBY N; CIOFU O; JENSEN T; PRESSLER T; JOHANSEN HK; KOCH C
      USE OF CARBAPENEMS AND OTHER ANTIBIOTICS FOR PULMONARY INFECTIONS IN PATIENTS WITH CYSTIC-FIBROSIS

      The Pediatric infectious disease journal
    65. ZIMAKOFF J; PEDERSEN FB; BERGEN L; BAAGONIELSEN J; DALDORPH B; ESPERSEN F; HANSEN BG; HOIBY N; JEPSEN OB; JOFFE P; KOLMOS HJ; KLAUSEN M; KRISTOFFERSEN K; LADEFOGED J; OLESENLARSEN S; ROSDAHL VT; SCHEIBEL J; STORM B; TOFTEJENSEN P; LOKKEGAARD H; NIELSEN B; WURR M; WANG P; ANTONSEN S; ERIKSEN NR; LADEFOGED SD
      STAPHYLOCOCCUS-AUREUS CARRIAGE AND INFECTIONS AMONG PATIENTS IN 4 HAEMO-DIALYSIS AND PERITONEAL-DIALYSIS CENTERS IN DENMARK

      The Journal of hospital infection
    66. BENNEKOV T; COLDING H; OJENIYI B; BENTZON MW; HOIBY N
      COMPARISON OF RIBOTYPING AND GENOME FINGERPRINTING OF PSUDEOMONAS-AERUGINOSA ISOLATES FROM CYSTIC-FIBROSIS PATIENTS

      Journal of clinical microbiology
    67. PETERSEN TD; CIOFU O; PRESSLER T; GIWERCMAN B; PEDERSEN SS; HOIBY N
      QUANTITATIVE-ANALYSIS OF THE IGG AND IGG SUBCLASS IMMUNE-RESPONSES TOCHROMOSOMAL PSEUDOMONAS-AERUGINOSA BETA-LACTAMASE IN SERUM FROM PATIENTS WITH CYSTIC-FIBROSIS BY WESTERN BLOTTING AND LASER-SCANNING DENSITOMETRY

      Thorax
    68. DURACK DT; GATELY MK; HOIBY N; JOHNNY KV; UTILI R
      INTERLEUKIN-12 - POTENTIAL CLINICAL-APPLICATIONS IN THE TREATMENT ANDPREVENTION OF INFECTIOUS-DISEASES - DISCUSSION

      Drugs
    69. MUKHTAR AH; LECLERCQ R; HOIBY N; KLUGMAN KP
      EPIDEMIOLOGY AND CONTROL OF MULTIRESISTANT ENTEROCOCCI - DISCUSSION

      Drugs
    70. GLAUSER MP; WEBER F; HOIBY N; STILLE W; KUNGU C; VERNAZZA P
      THE CHALLENGE OF CHANGING HEALTH-CARE SYSTEMS - DISCUSSION

      Drugs
    71. FINCH RG; WIEDEMANN B; GLAUSER MP; DAVEY PG; HOIBY N
      EPIDEMIOLOGY, CONTROL AND TREATMENT OF MULTIRESISTANT GRAM-NEGATIVE RODS - DISCUSSION

      Drugs
    72. JOHANSEN HK; HOUGEN HP; RYGAARD J; HOIBY N
      INTERFERON-GAMMA (IFN-GAMMA) TREATMENT DECREASES THE INFLAMMATORY RESPONSE IN CHRONIC PSEUDOMONAS-AERUGINOSA PNEUMONIA IN RATS

      Clinical and experimental immunology
    73. PRESSLER T; JENSEN ET; ESPERSEN F; PEDERSEN SS; HOIBY N
      HIGH-LEVELS OF COMPLEMENT-ACTIVATION CAPACITY IN SERA FROM PATIENTS WITH CYSTIC-FIBROSIS CORRELATE WITH HIGH-LEVELS OF IGG3 ANTIBODIES TO PSEUDOMONAS-AERUGINOSA ANTIGENS AND POOR LUNG-FUNCTION

      Pediatric pulmonology
    74. HOIBY N
      EPIDEMIOLOGIC ASPECTS ON ANTIBIOTIC-RESISTANCE

      Microbial drug resistance
    75. JOHANSEN HK; HOUGEN HP; CRYZ SJ; RYGAARD J; HOIBY N
      VACCINATION PROMOTES TH1-LIKE INFLAMMATION AND SURVIVAL IN CHRONIC PSEUDOMONAS-AERUGINOSA PNEUMONIA IN RATS

      American journal of respiratory and critical care medicine
    76. JOHANSEN HK; NORGAARD A; ANDERSEN LP; JENSEN P; NIELSEN H; HOIBY N
      CROSS-REACTIVE ANTIGENS SHARED BY PSEUDOMONAS-AERUGINOSA, HELICOBACTER-PYLORI, CAMPYLOBACTER-JEJUNI, AND HAEMOPHILUS-INFLUENZAE MAY CAUSE FALSE-POSITIVE TITERS OF ANTIBODY TO HELICOBACTER-PYLORI

      Clinical and diagnostic laboratory immunology
    77. FOMSGAARD A; HOIBY N; FRIIS HM; GAHRNHANSEN B; KOLMOS HJJ; SCHOUENBORG P; KORSAGER B; TVEDE M; GUTSCHIK E; BREMMELGAARD A
      PREVALENCE AND ANTIBIOTIC-SENSITIVITY OF DANISH VERSUS OTHER EUROPEANBACTERIAL ISOLATES FROM INTENSIVE-CARE AND HEMATOLOGY-ONCOLOGY UNITS

      European journal of clinical microbiology & infectious diseases
    78. LANGE KHW; HOUGEN HP; HOIBY N; FOMSGAARD A; RYGAARD J; JOHANSEN HK
      EXPERIMENTAL CHRONIC PSEUDOMONAS-AERUGINOSA LUNG INFECTION IN RATS - NONSPECIFIC STIMULATION WITH LPS REDUCES LETHALITY AS EFFICIENTLY AS SPECIFIC IMMUNIZATION

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    79. GARDE AH; FOMSGAARD A; HOIBY N
      AN EASY MICROTITER ASSAY FOR QUANTITATION OF CYTOKINE INDUCTION BY LIPOPOLYSACCHARIDE (LPS) AND ACTIVITY OF LPS-BINDING SERUM COMPONENTS

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    80. JENSEN P; FOMSGAARD A; HOIBY N; HINDERSSON P
      CLONING AND NUCLEOTIDE-SEQUENCE COMPARISON OF THE GROE OPERON OF PSEUDOMONAS-AERUGINOSA AND BURKHOLDERIA-CEPACIA

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    81. BANGSBORG JM; HINDERSSON P; SHAND G; HOIBY N
      THE LEGIONELLA-MICDADEI FLAGELLIN - EXPRESSION IN ESCHERICHIA-COLI K-12 AND DNA-SEQUENCE OF THE GENE

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    82. CIOFU O; GIWERCMAN B; WALTERRASMUSSEN J; PRESSLER T; PEDERSEN SS; HOIBY N
      ANTIBODIES AGAINST PSEUDOMONAS-AERUGINOSA CHROMOSOMAL BETA-LACTAMASE IN PATIENTS WITH CYSTIC-FIBROSIS ARE MARKERS OF THE DEVELOPMENT OF RESISTANCE OF PSEUDOMONAS-AERUGINOSA TO BETA-LACTAMS

      Journal of antimicrobial chemotherapy
    83. HOIBY N
      ISOLATION AND TREATMENT OF CYSTIC-FIBROSIS PATIENTS WITH LUNG INFECTIONS CAUSED BY PSEUDOMONAS-(BURKHOLDERIA)-CEPACIA AND MULTIRESISTANT PSEUDOMONAS-AERUGINOSA

      Netherlands journal of medicine
    84. ZEMBRZUSKASADKOWSKA E; SNEUM M; OJENIYI B; HEIDEN L; HOIBY N
      EPIDEMIOLOGY OF PSEUDOMONAS-AERUGINOSA INFECTION AND THE ROLE OF CONTAMINATION OF THE ENVIRONMENT IN THE DANISH CYSTIC-FIBROSIS CENTER

      The Journal of hospital infection
    85. HOIBY N; JOHANSEN HK; JARLOV JO; WESTH H; PRAG JB; BANGSBORG JM; MOSER C; KEMP M; HORNSLETH AK; HANSEN H
      CIPROFLOXACIN IN SWEAT AND ANTIBIOTIC-RESISTANCE

      Lancet
    86. BANGSBORG JM; GERNERSMIDT P; COLDING H; FIEHN NE; BRUUN B; HOIBY N
      RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM OF RIBOSOMAL-RNA GENES FOR MOLECULAR TYPING OF MEMBERS OF THE FAMILY LEGIONELLACEAE

      Journal of clinical microbiology
    87. LAURSEN EM; JUUL A; LANNG S; HOIBY N; KOCH C; MULLER J; SKAKKEBAEK NE
      DIMINISHED CONCENTRATIONS OF INSULIN-LIKE GROWTH-FACTOR-I IN CYSTIC-FIBROSIS

      Archives of Disease in Childhood
    88. DORING G; KROGHJOHANSEN H; WEIDINGER S; HOIBY N
      ALLOTYPES OF ALPHA(1)-ANTITRYPSIN IN PATIENTS WITH CYSTIC-FIBROSIS, HOMOZYGOUS AND HETEROZYGOUS FOR DELTAF508

      Pediatric pulmonology
    89. PRESSLER T; JENSEN ET; ESPERSEN F; PEDERSEN SS; HOIBY N; KOCH C
      CORRELATION BETWEEN SPECIFIC IGG SUBCLASS ANTIBODIES TO PSEUDOMONAS-AERUGINOSA AND OPSONIC ACTIVITY IN SERUM FROM PATIENTS WITH CYSTIC-FIBROSIS

      Pediatric pulmonology
    90. CIOFU O; GIWERCMAN B; PEDERSEN SS; HOIBY N
      DEVELOPMENT OF ANTIBIOTIC-RESISTANCE IN PSEUDOMONAS-AERUGINOSA DURING2 DECADES OF ANTIPSEUDOMONAL TREATMENT AT THE DANISH-CF-CENTER

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    91. JOHANSEN HK; CRYZ SJ; HOIBY N
      CLEARANCE OF PSEUDOMONAS-AERUGINOSA FROM NORMAL RAT LUNGS AFTER IMMUNIZATION WITH SOMATIC ANTIGENS OR TOXIN-A

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    92. REIMERT CM; GIWERCMAN B; HOIBY N; KHARAZMI A
      EOSINOPHIL CATIONIC PROTEIN IN SPUTUM FROM CYSTIC-FIBROSIS PATIENTS WITH PSEUDOMONAS-AERUGINOSA INFECTIONS

      Lancet
    93. PRESSLER T; MANSA B; PEDERSEN SS; ESPERSEN F; HOIBY N; KOCH C
      METHODOLOGIC PROBLEMS IN ESTABLISHING NORMAL VALUES FOR IGG SUBCLASS CONCENTRATIONS IN A PEDIATRIC POPULATION - COMPARISON OF RADIAL IMMUNODIFFUSION AND ELISA METHODS

      Allergy
    94. GIWERCMAN B; RASMUSSEN JW; CIOUFU O; CLEMMENTSEN I; SCHUMACHER H; HOIBY N
      ANTIBODIES AGAINST CHROMOSOMAL BETA-LACTAMASE

      Antimicrobial agents and chemotherapy
    95. SILVA FDE; BARANOV V; BARBERO GJ; BRODY SL; DORING G; GOTZ M; HODSON ME; HOIBY N; KAPRANOV N; KNOWLES MR; LANNEFORS L; MASTELLA G; NOIRCLERC M; QUINTON PM; SHALE DJ; SHEPHERD R; WIILIAMSON R; WEIBEL M; BOULYJENKOV V
      THERAPEUTIC APPROACHES TO CYSTIC-FIBROSIS - MEMORANDUM FROM A JOINT WHO ICF(M)A MEETING

      Bulletin of the World Health Organization
    96. HOIBY N
      DIFFUSE PANBRONCHIOLITIS AND CYSTIC-FIBROSIS - EAST MEETS WEST

      Thorax
    97. BIERINGSORENSEN F; HOIBY N; NORDENBO A; RAVNBORG M; BRUUN B; RAHM V
      CIPROFLOXACIN AS PROPHYLAXIS FOR URINARY-TRACT INFECTION - PROSPECTIVE, RANDOMIZED, CROSSOVER, PLACEBO-CONTROLLED STUDY IN PATIENTS WITH SPINAL-CORD LESION - REPLY

      The Journal of urology
    98. BIERINGSORANSEN F; HOIBY N; NORDENBO A; RAVNBORG M; BRUUM B; RATH V
      CIPROFLOXACIS AS PROPHYLAXIS FOR URINARY-TRACT INFECTION - PROSPECTIVE, RANDOMIZED, CROSS-OVER, PLACEBO-CONTROLLED STUDY IN PATIENTS WITH SPINAL-CORD

      The Journal of urology
    99. BIERINGSORENSEN F; HOIBY N; NORDENBO A; RAVNBORG M; BRUUN B; RAHM V
      CIPROFLOXACIN AS PROPHYLAXIS FOR URINARY-TRACT INFECTION - PROSPECTIVE, RANDOMIZED, CROSS-OVER, PLACEBO-CONTROLLED STUDY IN PATIENTS WITH SPINAL-CORD LESION

      The Journal of urology
    100. SPEERT D; CAMPBELL M; PUTERMAN ML; GOVEN J; DOHERTY C; HOIBY N; OJENIYI B; LAM JS; OGLE JW; JOHNSON Z; PARANCHYCH W; SASTRY PA; PITT TL; LAWRANCE L
      A MULTICENTER COMPARISON OF METHODS FOR TYPING STRAINS OF PSEUDOMONAS-AERUGINOSA PREDOMINANTLY FROM PATIENTS WITH CYSTIC-FIBROSIS

      The Journal of infectious diseases


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 05:35:39